Resignation of CEO & MD and appointment new CFO
Filed with ASX · · 2 pages · English
HeraMED Limited (ASX:HMD) (“HeraMED” or the “Company”) a medical data and technology company leading the digital transformation of maternity care, today announced that Mr David Groberman has resigned as Chief Executive Officer and Managing Director with immediate effect. David will continue in a non-Executive role, as Product Strategist, delivering advice and strategic input on the evolution of th
Earlier from HeraMED
- HeraMED completes AU$2.58 million Private Placement
- E-Lovu signs first 3 year commercial agreement
- Further information - Strategic Partnership Rewards Platform
- Strategic Partnership signed - US employee rewards platform
- Contract signed with private Obstetrics & Gynaecology Group
Later from HeraMED
- Clinical Trial launched at Gold Coast Hospital
- Signed Partner Agreement with Telstra Health
- Placement completed successfully raising $1.25 million
- MOU signed with US-based FemBridge - maternity care solution
- USA-based Wingwomen signs MoU - launch 'Cardio Care'
Follow HeraMED into a list and get an email when it puts out news.
Follow HeraMED